RC
Roth Capital Latest Price Targets & Analyst Ratings
| Stock | Analyst | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|---|
351
Applied DNA Sciences
APDN
$3.09M
|
JA
Jonathan Aschoff
| $2.39 | $360,000 |
15,062,662%
upside
| Buy |
12 Feb ‘21
4 years ago |
|
352
Usana Health Sciences
USNA
$555M
|
DB
David Bain
| $30.36 | $126 |
315%
upside
| Buy |
10 Feb ‘21
4 years ago |
|
353
ChargePoint
CHPT
$245M
|
CI
Craig Irwin
| $10.50 | $46 |
338%
upside
| Buy |
5 Feb ‘21
4 years ago |
|
354
Silicon Laboratories
SLAB
$4.45B
|
SD
Suji Desilva
| $135.56 | $150 |
11%
upside
| Buy |
4 Feb ‘21
4 years ago |
|
355
Clene
CLNN
$65.9M
|
EP
Elemer Piros
| $6.60 | $480 |
7,173%
upside
| Buy |
3 Feb ‘21
4 years ago |
|
356
Tetra Tech
TTEK
$9.22B
|
GS
Gerry Sweeney
| $35.10 | $27 |
23%
downside
| Buy |
1 Feb ‘21
4 years ago |
|
357
Monopar Therapeutics
MNPR
$277M
|
EP
Elemer Piros
| $44.93 | $245 |
445%
upside
| Buy |
28 Jan ‘21
4 years ago |
|
358
Zevra Therapeutics
ZVRA
$461M
|
JA
Jonathan Aschoff
| $8.21 | $28 |
241%
upside
| Buy |
25 Jan ‘21
4 years ago |
|
359
Arcturus Therapeutics
ARCT
$487M
|
EP
Elemer Piros
| $17.94 | $77 |
329%
upside
| Sell |
23 Dec ‘20
4 years ago |
|
360
Cambium Networks
CMBM
$18.8M
| $0.6646 | $35 |
5,166%
upside
| Buy |
8 Dec ‘20
4 years ago |
|
|
|
CBIO
361
Crescent Biopharma, Inc. Common Stock
CBIO
$174M
| $12.55 | $1,500 |
11,852%
upside
| Buy |
8 Dec ‘20
4 years ago |
|
|
362
CRISPR Therapeutics
CRSP
$4.88B
|
TB
Tony Butler
| $53.69 | $170 |
217%
upside
| Buy |
7 Dec ‘20
4 years ago |
|
363
Inovio Pharmaceuticals
INO
$146M
|
JA
Jonathan Aschoff
| $2.75 | $96 |
3,391%
upside
| Sell |
17 Nov ‘20
4 years ago |
|
364
Energy Fuels
UUUU
$3.02B
| $13.08 | $2.50 |
81%
downside
| Buy |
12 Nov ‘20
4 years ago |
|
|
365
Uranium Energy
UEC
$5.37B
|
JR
Joseph Reagor
| $12.09 | $2.40 |
80%
downside
| Buy |
12 Nov ‘20
4 years ago |
|
366
Warrior Met Coal
HCC
$3.06B
| $58.29 | $20 |
66%
downside
| Buy |
12 Nov ‘20
4 years ago |
|
|
367
Myomo
MYO
$35.9M
|
SH
Scott Henry
| $0.9508 | $7 |
636%
upside
| Buy |
11 Nov ‘20
4 years ago |
|
368
BGSF Inc
BGSF
$71.3M
| $6.39 | $17.50 |
174%
upside
| Buy |
6 Nov ‘20
4 years ago |
|
|
369
Broadwind
BWEN
$48.8M
| $2.12 | $4 |
89%
upside
| Buy |
5 Nov ‘20
4 years ago |
|
|
370
Intrepid Potash
IPI
$380M
| $28.55 | $11 |
61%
downside
| Buy |
4 Nov ‘20
4 years ago |
|
|
371
MGM Resorts International
MGM
$9.8B
|
DB
David Bain
| $36 | $20 |
44%
downside
| Neutral |
30 Oct ‘20
4 years ago |
|
372
Darling Ingredients
DAR
$5.01B
|
CI
Craig Irwin
| $31.64 | $84 |
165%
upside
| Buy |
22 Oct ‘20
4 years ago |
|
373
Workhorse Group
WKHS
$18.3M
|
AS
Andrew Scutt
| $1.19 | $6,750 |
567,127%
upside
| Neutral |
14 Oct ‘20
4 years ago |
|
|
HYPD
374
Hyperion DeFi, Inc. Common Stock
HYPD
$49.8M
| $8.75 | $880 |
9,957%
upside
| Buy |
14 Oct ‘20
4 years ago |
|
|
375
Fortress Biotech
FBIO
$107M
| $3.59 | $71.25 |
1,885%
upside
| Buy |
13 Oct ‘20
4 years ago |
|